Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 6;15(1):334.
doi: 10.1038/s41467-023-44589-x.

A role and mechanism for redox sensing by SENP1 in β-cell responses to high fat feeding

Affiliations

A role and mechanism for redox sensing by SENP1 in β-cell responses to high fat feeding

Haopeng Lin et al. Nat Commun. .

Abstract

Pancreatic β-cells respond to metabolic stress by upregulating insulin secretion, however the underlying mechanisms remain unclear. Here we show, in β-cells from overweight humans without diabetes and mice fed a high-fat diet for 2 days, insulin exocytosis and secretion are enhanced without increased Ca2+ influx. RNA-seq of sorted β-cells suggests altered metabolic pathways early following high fat diet, where we find increased basal oxygen consumption and proton leak, but a more reduced cytosolic redox state. Increased β-cell exocytosis after 2-day high fat diet is dependent on this reduced intracellular redox state and requires the sentrin-specific SUMO-protease-1. Mice with either pancreas- or β-cell-specific deletion of this fail to up-regulate exocytosis and become rapidly glucose intolerant after 2-day high fat diet. Mechanistically, redox-sensing by the SUMO-protease requires a thiol group at C535 which together with Zn+-binding suppresses basal protease activity and unrestrained β-cell exocytosis, and increases enzyme sensitivity to regulation by redox signals.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Higher insulin secretion and β-cell exocytosis from islets of overweight donors and 2-day HFD mice.
A Insulin secretion from islets of young (21–45 years) donors at 1 (n = 27, 47, 5), 10 (n = 27, 41, 4) and 16.7 mM (n = 27, 47, 5) glucose. Effect of glucose (**p = 0.0010; ***p = 1 × 10−11) and vs BMI < 25 (&p = 0.034). B Exocytosis from β-cells of young (21–45) donors at 1 (n = 55, 120, 22), 5 (n = 130, 236, 36) and 10 mM (n = 88, 151, 21) glucose. Effect of glucose (**p = 0.0056; ***p = 4.6 × 10−7), vs BMI < 25 (&&p = 0.0039), vs T2D BMI > 25 ($p = 0.046; #p = 0.028). C Insulin secretion from islets of older (>45 years) donors 1 (n = 61, 111, 21), 10 (n = 40, 88, 18) and 16.7 mM (n = 55, 110, 21) glucose. Effect of glucose (**p = 0.0029; ***p = 2.3 × 10−10, 2.8 × 10−7), vs BMI < 25 (&&p = 0.0047), vs T2D BMI > 25 ($p = 0.040). D Exocytosis from β-cells of older (>45 years) donors at 1 (n = 164, 285, 78), 5 (n = 310, 474, 112) and 10 mM (n = 173, 364, 112) glucose. Effect of glucose (*p = 0.031; ***p = 7.9 × 10−11; 5.8 × 10−11), vs BMI > 25 (###p = 1.8 × 10−4), vs BMI > 25 ($$$p = 5.3 × 10−5). Data in AE compared by two-way ANOVA followed by Tukey post-test. See Supplementary Fig. 1 for breakdown by sex and donor. E IPGTT of mice after CD and 2-day HFD (n = 14, 14). F Plasma insulin during IPGTT (n = 7, 7; **p = 0.0077). G, H Insulin secretion (panel G; n = 10, 11; ***p = 5.1 × 10−5; **p = 0.0015, *p = 0.041, 0.011) and content (panel H; n = 11, 12). AUC – area under the curve (*p = 0.019). I Representative traces (left), and average total responses, of β-cell exocytosis at 2.8 and 10 mM glucose (n = 21, 26, 32, 33 cells, @p = 0.017, from 3 pairs of mice, *p = 0.015, 0.040). J Representative traces, and average Ca2+ currents, of β-cells at 2.8 and 10 mM glucose (n = 9, 22, 19, 19 cells, *p = 0.023, 0.026, from 3 pairs of mice). K Single cell [Ca2+]i response (n = 16, 34 cells from 4, 5 mice). Data are mean ± SEM, compared with student unpaired Student’s t test (two-sided; panels G, H, K) or two-way ANOVA followed by Tukey post-test (panels F, G, I, J), uncorrected Fisher’s LSD (panel J) or RM two-way ANOVA with matching and Bonferroni post-test (panel I). Source data are provided as a Source Data file.
Fig. 2
Fig. 2. RNA sequencing of purified β-cells following 2-day HFD.
A β-cells from CD and 2-day HFD were isolated through fluorescence activated cell sorting (FACS) for RNA sequencing. 213 genes were identified differentially expressed (DE) genes after 2-day HFD (213 genes, n = 4 and 3 mice). No adjustments were made for multiple comparisons. B All DE genes were submitted to Metascape for functional enrichment analysis using the standard accumulative hypergeometric statistical test. Expression of DE genes on CD and HFD were normalized to z-scores by gene and colorized in circos heat map. The six most enriched pathways (PW) are shown. All DE genes were submitted to STRING database for protein-protein interaction. The related protein interactions for DE genes enriched in the six PW were highlighted as links in the circos plot. C Gene set enrichment analysis (GSEA) showed significant up- and down-regulated pathways after HFD with false discovery rate (FDR) less than 0.05. All nominal p-values were less than 0.01. Normalized enrichment score (NES) reflects the degree to which a gene set is overrepresented in a ranked list of genes. D Illustration of transcriptomic changes related to metabolism after 2-day HFD. Raw sequencing data available in the GEO repository (GSE249790).
Fig. 3
Fig. 3. Reductive cytosolic redox signaling via SENP1 contributes to enhanced exocytosis during 2-day HFD.
A Oxygen consumption rate (OCR) measured by Seahorse assay (n = 6 pairs of mice, *p = 0.017, 0.030; **p = 0.0039), with relevant respiration parameters calculated at right as shown by italicized numbers (**p = 0.0036, 0.0089). B Basal OCR measured by Fluorescence Lifetime Micro Oxygen Monitoring at 2.8 mM glucose (n = 4, 5 mice; *p = 0.018). C Representative image of pancreatic islets (white dashed circle) carrying cyto-roGFP2-Orp1 sensor (left). Scale bar = 100 µm. Redox ratio of individual islets (n = 65, 41 islets, @@@p = 1.3 × 10−12, from 6 pairs of mice, *p = 0.041). D, E Exocytosis with infusion of 10 µM GSH (panel D; n = 27, 30, 31, 38 cells, @p = 0.046, 0.017; from 4 pairs of mice, *p = 0.026, **p = 0.0073) or 200 µM H2O2 (panel E; n = 43, 39, 56, 39 cells, @@@p = 7.1 × 10−6, 2.9 × 10−4; from 7 pairs of mice, *p = 0.015, 0.022) at 2.8 mM glucose after 2-day HFD. F Illustration of redox-control of insulin exocytosis. GRX1-glutaredoxin 1; GSH – reduced glutathione; GSSG- glutathione; SENP1- sentrin-specific SUMO-protease 1. G Senp1 expression by qRT-PCR in islets from CD or HFD fed mice (n = 7, 7, 8, 9, 4, 2 mice, **p = 0.0017). H Exocytosis with infusion of 4 μg/mL catalytic SENP1 (n = 21, 32, 31, 33 cells, @p = 0.032, 0.026, @@p = 0.0044; from 4 pairs of mice, *p = 0.18) at 2.8 mM glucose. In panels C, D, E, H data are shown as individual cells (gray) or cells averaged by animal (dark). Data are mean ± SEM, compared with students paired t-test (two-sided; panels AC) or RM two-way ANOVA with matching and Bonferroni post-test (panel A), or two-way ANOVA followed by Tukey post-test (panels D, E, G, H). Levels of significance are indicated for analysis with cells as replicates (‘@’) or with animals as replicates (*). @/*P < 0.05, @@/**P < 0.01, @@@/***P < 0.001 versus CD or as indicated. Source data are provided as a Source Data file.
Fig. 4
Fig. 4. βSENP1-KO mice develop glucose intolerance following 2-day HFD.
A, B IPGTT of male pSENP1-KO and pSENP1-WT mice fed with CD (n = 9, 8 mice) and 2-HFD (n = 10, 11 mice, *p = 0.023, 0.027). C, D OGTT of male pSENP1-KO and pSENP1-WT mice fed with CD (n = 6, 6 mice) and 2-HFD (n = 10, 8 mice, *p = 0.019, **p = 0.0017). E, F Exocytosis from β-cells of βSENP1-WT and βSENP1-KO mice after 2-day (n = 34, 32, 24, 34, 56, 56, 18, 21 cells, @@p = 0.0017, 0.0018, 0.0032, 0.0030; from 4, 3, 6, 2 mice, *p = 0.020, **p = 0.0029, 0.0036, 0.0092, 0.0097) and 4-week HFD (n = 46, 45, 32, 31, 48, 56, 68, 63 cells, @p = 0.031, 0.021, @@p = 0.0011, 0.0017, 0.0044; from 4, 3, 4, 6 mice, *p = 0.027, 0.044). G, H IPGTT of male βSENP1-KO and βSENP1-WT mice fed with CD (n = 6, 5 mice) and 2-day HFD (n = 10, 12 mice, *p = 0.044, 0.025). I Plasma insulin levels during IPGTT after CD or 2-day HFD (n = 8, 8 mice, **p = 0.0049). J, K OGTT of male βSENP1-KO and βSENP1-WT mice fed with CD (n = 4, 4 mice) and 4-week HFD (n = 13, 11 mice, *p = 0.021, 0.040, 0.050, 0.023). L Plasma insulin levels during OGTT after CD or 4-week HFD (n = 8, 8 mice, *p = 0.017). In panels E and F data are shown as individual cells (gray) or cells averaged by animal (dark). Data are mean ± SEM, compared with student two-sided unpaired Student’s t test (AUCs) or two-way ANOVA followed either by Bonferroni (two-sided; panels AD, GL) or Tukey (two-sided; panels E, F) post-test. Source data are provided as a Source Data file.
Fig. 5
Fig. 5. Redox regulation of SENP1 activity requires C535.
A Multiple amino acid comparison among different isoforms of SENP across species. B SENP1 activity after indicated cysteine-to-serine substitution (n = 3 experiments, **p = 0.0034, 0.0020, ***p = 0.00040, 0.00079). C SENP1 activity after cysteine-to-serine mutation and subsequent mutation of histidine 533 or aspartic acid 550 to serine (n = 5 experiments, ***p = <1 × 10−15, <1 × 10−15, <1 × 10−15, 6.1 × 10−7). Control here was C608S that does not affect activity, but used to balance thiol groups. D SENP1 activity of control (C608S) SENP1 compared with serine mutants in the presence of H2O2 (100 μM), excess histidine (1 mM), or both (n = 4 experiments, Control: ***p = 2.6 × 10−9, <1 × 10−15, <1 × 10−15, 3.8 × 10−8, 9.8 × 10−8; C535S: **p = 0.0013, ***p = 4.6 × 10−9, <1 × 10−15, <1 × 10−15 5.9 × 10−7; C535S/D550S: *p = 0.012, ***p = 8.3 × 10−4, 1.3 × 10−8, 4.9 × 10−6). E Activity of SENP1 C603S, WT, and C535S upon full activation by DTT (10 mM), and subsequent inhibition by 5 mM H2O2 (n = 3 experiments, **p = 0.0024, ***p = 0.9.6 × 10−9). F In β-cells from pSENP1-KO (red) mice the effect of 4 μg/mL glutathione-S-transferase (GST) peptide (Control), SENP1 WT, or C535S were infused with/without 10 µM H2O2 on exocytosis at 5 mM glucose compared with pSENP-WT β-cells (black) (n = 30, 21, 24, 26, 21, 29 cells, @p = 0.015, @@p = 0.0062, 0.0025, @@@p = 5.4 × 10−5, 9.6 × 10−4, 1.1 × 10−5; from 3, 3 mice, *p = 0.040, 0.033, 0.011, **p = 0.0031, 0.0089, 0.0026). G Activity of SENP1 C603S, WT, and C535S in the presence of GSH (0.1 mM) alone or with GRX1 (10 μg/ml). DTT (10 mM) was used to fully activate the enzymes (n = 3 experiments, ***p = 3.3 × 10−4, 5.8 × 10−4, 7.5 × 10−5, 1.3 × 10−4). In panel F data are shown as individual cells (gray) or cells averaged by animal (dark). Data are mean ± SEM, compared with RM one-way ANOVA followed by Tukey post-test (panels B, F) or two-way ANOVA followed by Tukey (panels C, D, G) or Bonferroni (panel E) post-test within groups. Source data are provided as a Source Data file.
Fig. 6
Fig. 6. Zn2+ tunes SENP1 redox sensitivity and SENP1-dependent β-cell exocytosis.
A Activity of SENP1 WT and C535S in the presence or absence of Ca2+, Co2+, Ni2+ and Zn2+ (n = 3 experiments, **p = 0.0071, ***p = 0.00029). Data were normalized to C535S activity, as this is more resistant to oxidation. B Dose-response curve of SENP1 inhibition by ZnCl2 (n = 3 experiments, ***p = 1.9 × 10−14). C SENP1 inhibition by ZnCl2 could be reversed with the chelating reagent EDTA (n = 4 experiments, ***p = 1.6 × 10−8). DF SENP1 activity, measured using a native-PAGE assay, inhibited by Zn2+-carrying (MT1X, panel D, ***p = <1 × 10−15, 1.5 × 10−6, 1.5 × 10−12) but not Zn2+-depleted (T1X, panel E) metallothionine or by Zn2+-carrying MT1X in the presence of EDTA (panel F, ***p = all are 1.9 × 10−14) (n = 6 experiments). G Effect of Zn2+ on exocytosis from β-cells of βSENP1-WT and -KO mice at 5 mM glucose (n = 46, 35, 46, 39, 23, 23 cells, @p = 0.023, @@p = 0.0035, 0.0041, 0.0012, @@@p = 7.4 × 10−7; from 6, 6, 3 pairs of mice, *p = 0.030, **p = 0.030). H Concentration-response curve of SENP1 activity, with enzyme prepared with or without ZnCl2 during refolding, to inhibition by H2O2. Activity of SENP1 C603S is shown for comparison (n = 6 experiments). I Activity of SENP1 C603S, WT, and C535S in the presence of 1 µM Zn2+ and subsequent activation with 5 mM GSH and 10 µg/ml GRX1. 2-mercaptoethanol (2-ME, 1 mM) was used to fully activate enzymes (n = 4 experiments, *p = 0.014, ***p = 3.5 × 10−6, 5.1 × 10−10, 5.1 × 10−11, 2.6 × 10−6, 6.5 × 10−5). In panel G data are shown as individual cells (gray) or cells averaged by animal (dark). Data are mean ± SEM, compared with RM one-way ANOVA followed by Tukey post-test (panels CF) or RM two-way ANOVA followed by Bonferroni post-test within groups (panels A, I) or across conditions (panels B, G). Source data are provided as a Source Data file.

References

    1. Chen C, Cohrs CM, Stertmann J, Bozsak R, Speier S. Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis. Mol. Metab. 2017;6:943–957. doi: 10.1016/j.molmet.2017.06.019. - DOI - PMC - PubMed
    1. Perley MJ, Kipnis DM. Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects. J. Clin. Invest. 1967;46:1954–1962. doi: 10.1172/JCI105685. - DOI - PMC - PubMed
    1. Polonsky KS, Given BD, Van E. Cauter, Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J. Clin. Invest. 1988;81:442–448. doi: 10.1172/JCI113339. - DOI - PMC - PubMed
    1. Elbein SC, Wegner K, Kahn SE. Reduced beta-cell compensation to the insulin resistance associated with obesity in members of Caucasian familial type 2 diabetic kindreds. Diabetes Care. 2000;23:221–227. doi: 10.2337/diacare.23.2.221. - DOI - PubMed
    1. Chen C, et al. Alterations in β-cell calcium dynamics and efficacy outweigh islet mass adaptation in compensation of insulin resistance and prediabetes onset. Diabetes. 2016;65:2676–2685. doi: 10.2337/db15-1718. - DOI - PubMed

Publication types

Associated data

LinkOut - more resources